Argenomics – Alberto Saul, President – Argentina
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
Address: Cochabamba 2525, (C1252AAO), Buenos Aires,Argentina
Tel: +54 11 4122 5800
Web: http://www.baliarda.com.ar/
A very strong local Argentinean pharmaceutical company, Baliarda was founded over 70 years ago, and is still family-owned and run. Capitalizing on Argentina’s strong human resource base, the company is dedicated to innovation and development of the best quality products at the best prices for patients. This philosophy of innovation extends to every level within the company, which has a very strong and dynamic sales-force countrywide, and state-of-the-art management software to track sales and meetings. Baliarda is even developing its own machinery to increase productivity and efficiency within their plant. Building on a solid reputation in the industry, Baliarda are an example of how hard work, a vision, quality and efficiency lead to success.
Corticosteroids, Pnemonology, Gastroenterology, Phlebology
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
The general manager of Ferring Argentina believes that the country has one of the strongest social security systems in Latin America, with high reimbursement levels and coverage for most chronic…
The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in the region for Roche, and…
The general manager of Gennoma Laboratorios Argentina weighs up the factors of why raising brand awareness using public television is the key success to his company communication strategy. When…
“In the last decade, as a result of high and sustained growth, the Argentine pharmaceutical industry increased production by more than 240 percent, which speaks volumes about the capacity of…
The country president of AstraZeneca Argentina discusses the country’s patent laws, the work being done to bring innovation back to Argentina, and the challenge of a strong branded generics market…
When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of operations. Novartis is a…
Roemmers fue establecida en 1921. ¿Cómo paso de ser una empresa familiar a la empresa que es hoy, y cuáles han sido los desafíos en el cambio en la cultura…
The executive management of Nycomed said in an interview that ‘the tremendous growth of the pharmaceutical industry will not occur in either Europe or the United States, but in emerging…
Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately after the regulation regarding…
Biogen Idec’s arrival in Argentina has been very recent. Could you explain to our readers why the time was right to take back your licences and to set up in…
What was the vision behind the creation of the umbrella organisation Amega Biotech in 2005? What led you to consider setting up an organisation with this structure, and offering these…
See our Cookie Privacy Policy Here
